EPEMED, the European Personalised Medicine Association, Appoints Executive Director

04-Jun-2010 - France

EPEMED has announced the appointment of Dr. Anne Bruinvels, an entrepreneur in personalised healthcare, as Executive Director and board member. Dr. Bruinvels will be responsible for growing the start-up organisation and, together with the board of directors, for building its strategic framework in creating guidance for all those involved in progressing personalised medicine with an emphasis on European market challenges.

Dr. Bruinvels started her work in personalised medicine more than 10 years ago. She has previously founded Elixior, a personalised healthcare advisory company and prior to that Curidium, a personalised medicine company identifying companion diagnostics and therapeutics to treat patients with central nervous system disorders. She was Curidium's CEO for more than six years and raised several rounds of funding before taking the company public on the AIM of the London Stock Exchange. Anne Bruinvels has also worked in research for various pharmaceutical companies, including SmithKline Beecham, Wyeth and Sandoz Pharma. She obtained her PhD (neuroscience) from Utrecht University (the Netherlands) and her MSc (pharmacy) from Groningen University (The Netherlands).

Other news from the department people

Most read news

More news from our other portals

Fighting cancer: latest developments and advances